Dr Fawad Hameedi, MD | |
79 Washington Ave, North Haven, CT 06473-1704 | |
(203) 456-8000 | |
Not Available |
Full Name | Dr Fawad Hameedi |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 79 Washington Ave, North Haven, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124318068 | NPI | - | NPPES |
008073005 | Medicaid | CT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 53890 (Connecticut) | Primary |
207Q00000X | Family Medicine | 53890 (Connecticut) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Fawad Hameedi, MD 79 Washington Ave, North Haven, CT 06473-1704 Ph: (203) 456-8000 | Dr Fawad Hameedi, MD 79 Washington Ave, North Haven, CT 06473-1704 Ph: (203) 456-8000 |
News Archive
A study released today by the Dental Health Foundation found that by third grade, almost two-thirds of California children have dental disease, making it the most prevalent children's health problem in the state.
MRO Corp., a leading provider of disclosure management applications and services for healthcare organizations, today announced the launch of software upgrades for Audit Tracker Online. The upgrades to MRO's request management program offer hospitals and health systems enhanced performance and functionality in effectively managing payer audits and denials from initial medical records request through appeals and payment resolution.
Deciphera Pharmaceuticals, a clinical stage biotechnology company focused on improved kinase inhibitor treatments for cancer, today announced the initiation of a Phase 1 clinical trial of its MET/TIE2/VEGFR2/TRK inhibitor altiratinib (DCC-2701).
For the third consecutive year, a diet created, studied and reported on by researchers at Rush University Medical Center has been ranked among the top five diets for 2018 in multiple categories by U.S. News & World Report.
A new report from the Institute for Scientific Information on Coffee (ISIC), a not-for-profit organisation devoted to the study and disclosure of science related to coffee and health, highlights the potential role of coffee consumption in reducing the risk of cognitive decline.
› Verified 3 days ago